Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Bcls Fund Iv Investments Gp, Llc

10% Owner at Kailera Therapeutics, Inc. (KLRA)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return-27.2%
vs. S&P 500-32.2%
Beat the market0%
Paper profit on buys−$6.9M
Total bought / sold$25.0M / $0

Reported trades

Filed Stock Type Shares Price Value Since
Apr 20SEC KLRAKailera Therapeutics, Inc. Buy 1,562,50022,583,268 held (+7%) $16.00 $25.0M -27.4%
  • Buy

    10% Owner Bcls Fund Iv Investments Gp, Llc bought $25.0M of KLRA at $16.00 — first open-market purchase in our records.